MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

03 Aug 2024 Evaluate
Revenue reduced marginally to stand at Rs. 226.06 millions during the quarter ended June 2024. The figure stood at Rs. 229.35 millions during the year-ago period.Net profit showed a marginal rise at Rs. 25.32 millions for the quarter ended June 2024, as compared to corresponding quarter of last year.Operating Profit saw a handsome growth to 43.08 millions from 41.45 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 226.06 229.35 -1.43 226.06 229.35 -1.43 956.40 957.49 -0.11
Other Income 0.74 0.12 516.67 0.74 0.12 516.67 2.42 2.38 1.68
PBIDT 43.08 41.45 3.93 43.08 41.45 3.93 230.60 184.45 25.02
Interest 0.20 0.16 25.00 0.20 0.16 25.00 1.07 1.33 -19.55
PBDT 42.88 41.29 3.85 42.88 41.29 3.85 229.53 183.12 25.34
Depreciation 9.04 8.31 8.78 9.04 8.31 8.78 34.36 32.33 6.28
PBT 33.84 32.98 2.61 33.84 32.98 2.61 195.17 150.79 29.43
TAX 8.52 8.30 2.65 8.52 8.30 2.65 50.16 37.45 33.94
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.50 -180.00
PAT 25.32 24.68 2.59 25.32 24.68 2.59 145.01 113.34 27.94
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 19.06 18.07 5.45 19.06 18.07 5.45 24.11 19.26 25.16
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..